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Research
Arsenic is often present in water as   inorganic 
arsenic (iAs). Although commonly found 
throughout nature, iAs is a human carcinogen 
(International Agency for Research on Cancer 
1980). Chronic As exposure has been associated 
with a large number of other consequences, 
including effects on neurologic, reproductive, 
developmental, genotoxic, and immunologic 
systems [Agency for Toxic Substances and 
Disease Registry (ATSDR) 2000].
Blood, urine, hair, and nails are used to 
assess As exposure and internal As levels in 
humans. Arsenic is rapidly metabolized after 
ingestion of iAs from drinking water and is 
excreted mainly through the urine in humans 
and most laboratory animals (Vahter 1999, 
2000). The urinary arsenic (uAs) level or the 
sum of As metabolites reflects the absorbed 
dose of iAs on an individual level, which pro­
vides a better quantitative estimate of recently 
absorbed As. Furthermore, it is a useful 
marker for ongoing ingestion of As because 
uAs methyla  tion indices have been found to 
be fairly stable for 8–10 months (Steinmaus 
et al. 2005).
Blood As levels are not as reliable of an 
indicator for monitoring chronic As expo­
sure in humans (ATSDR 2000) because As 
is rapidly cleared from the blood in most 
animals (Marafante et al. 1982; Vahter and 
Norin 1980; Yamauchi and Yamamura 1985). 
Arsenic tends to accumulate in hair and 
nails, but these samples may yield less accu­
rate results because of absorbed exogenous As 
contamination on external surfaces (ATSDR 
2000; Hindmarsh 2002).
Evaluation of As methylation efficiency 
is primarily based on quantifying the relative 
amounts of the different metabolites in urine. 
After iAs ingestion, approximately 60–90% 
of the exposure dosage is excreted in mam­
malian urine that consists of 10–30% As, 
10–20% monomethylarsonic acid (MMAV), 
and 60–80% dimethylarsinic acid (DMAV). 
The process of As methylation is considered a 
detoxification mechanism because the major 
methylated metabolites, such as MMAV and 
DMAV, are more readily excreted and less 
toxic than is iAs. However, recent studies have 
shown that higher urinary %MMAV is related 
to the risk of skin and bladder cancers as well as 
cardiovascular disease (Ahsan et al. 2007; Chen 
et al. 2003a, 2003b; Hsueh et al. 1997; Huang 
et al. 2007, 2008; Pu et al. 2007; Steinmaus 
et al. 2006; Tseng et al. 2005; Yu et al. 2000).
After chronic high­level As exposure, 
it may take substantial time to excrete the 
As after cessation of ingestion (Dewar and 
Lenihan 1956). Our previous studies showed 
that individuals with higher cumulative expo­
sure to iAs in the past had higher levels of 
urinary MMAV and DMAV, or %MMAV 
(Hsueh et al. 1998; Huang et al. 2007). A 
recent animal study found that after sub­
chronic exposure to As in mice, monomethyl­
arsonate preferentially accumulated in the 
kidney, whereas iAs and dimethylarsonate 
accumulated in the bladder (Kenyon et al. 
2008). These data imply that the uAs spe­
cies profiles might be an indicator of chronic 
high­level exposure to As in the past.
Endemic blackfoot disease (BFD) in south­
ern Taiwan and the switch from well water to a 
tap­water system provides a unique opportunity 
for determining the consequences of chronic As 
exposure and subsequent cessation of As inges­
tion. Residents from the BFD area had used 
artesian well water for more than 20 years when 
they were recruited in 1989 for the cohort to 
participate in the present study. This is the first 
study to investigate the effects of long­term 
As ingestion on the body after cessation of 
chronic As exposure through evaluation of the 
As methyla  tion indices. The purpose of this 
study is to examine the changes in uAs species 
profiles over 15 years (1989–2004) in cancer­
free residents in the BFD area. The influencing 
factors were also assessed in this study.
Methods
Study area and the study cohort. The original 
study cohort has been described in detail in 
our previous study (Chen et al. 1995). The 
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Ba c k g r o u n d: Inorganic arsenic (iAs) is carcinogenic to humans. Methylated metabolites of arsenic 
(As) found in the urine could serve as potential tools for screening and early detection of cancer in 
populations exposed to As. Relatively little information is available regarding changes in As methy-
lation profiles after cessation of As exposure. 
oB j e c t i v e: We examined the changes in urinary arsenic (uAs) species profiles over 15 years in a 
cancer-free population that has ceased heavy and prolonged ingestion of As. 
Me t h o d s : In 1989, a cohort study was carried out with 1,081 adults who resided in three villages 
in southwestern Taiwan where arseniasis was hyperendemic. After 15 years of follow-up, a subgroup 
of 205 cancer-free participants had completed all interviews and had uAs methylation data available. 
We used this group in our statistical analysis. Arsenic species were measured by high-performance 
liquid chromatography-hydride generation-atomic absorption spectrometry.
re s u l t s: We compared the initial analyses from 1989 with those performed 15 years later and 
found that the average differences for the proportion of urinary iAs, monomethylarsonic acid 
(MMAV), and dimethylarsinic acid (DMAV) were –4.90%, –6.80%, and 11.69%, respectively. The 
elderly and those residents with longer periods of consuming high-As artesian well water exhibited 
greater changes (decreases) in %MMAV.
co n c l u s i o n: The As methylation profiles indicate increased efficiency in As metabolism in resi-
dents after cessation of long-term exposure to high-level As. Moreover, the decreased %MMAV was 
more pronounced in the elderly cancer-free subcohort subjects.
key w o r d s : arsenic methylation, cumulative arsenic exposure, drinking water. Environ Health 
Perspect 117:1860–1866 (2009).  doi:10.1289/ehp.0900560 available via http://dx.doi.org/ [Online 
29 July 2009]Changes in intraindividual arsenic methylation profile
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present study was carried out in villages of 
Chayi County that have the highest frequency 
of BFD in Taiwan, with prevalence as high 
as 13.6%, 9.6%, and 10.3% in the villages 
of Homei, Fuhsing, and Hsinming, respec­
tively (Wu et al. 1961). Although a tap­water 
supply system was implemented in the early 
1960s, tap­water use remained low until the 
early 1970s. However, by the mid­1970s arte­
sian well water was no longer used in this area 
for drinking and cooking.
Residents ≥ 30 years of age (n = 2,258) 
were registered with the local household regis­
tration offices. Seventy percent of residents 
were eligible for our previous study if they 
were residing at least 5 days per week in the 
study villages. Sixty­nine percent (1,081 of 
1,571) of eligible residents provided informed 
consent and became part of the original study 
cohort. Home interviews with each participant 
were conducted between September 1988 
and December 1988. Participants were then 
invited, on a voluntary basis, to undergo a 
health examination, including the collection of 
a urine sample in January and February 1989 
(Figure 1A). The Institutional Review Board 
of National Taiwan University approved our 
previous study.
In August 2004, the original cohort resi­
dents from the 1989 study were invited to 
participate in the Chayi Community Based 
Integrated Screening (CCIS) program. The 
CCIS program is an integrated model of 
community­based mass screening and was 
conducted between 2002 and 2007 in 17 vil­
lages and townships in Chayi County. The 
flowchart of the recruited subcohort is shown 
in Figure 1B. Of the 1,081 residents from the 
original cohort, 72% (776) were invited by 
postcard to participate in the CCIS program. 
Thirty­two percent (247 of 776) of these 
invitees participated in the CCIS program in 
August 2004 and provided informed consent. 
Each participant’s unique national identifica­
tion number was used to link to the comput­
erized National Cancer Registry in Taiwan for 
the purpose of identifying diagnosed cancer 
cases between 1989 and 2003. After exclud­
ing 17 subjects who had developed cancer 
from 1989 to 2004, and another 25 subjects 
who provided incomplete questionnaires, a 
subgroup of 205 cancer­free residents of the 
original study cohort was available for the 
data analysis. The Institutional Review Board 
of Taipei Medical University approved the 
recruitment of the subcohort in 2004.
Questionnaire interview and determina-
tion of As exposure. The questionnaire inter­
view and the determination of As exposure of 
subjects residing in the endemic BFD villages 
of southwestern Taiwan have been reported 
previously (Chen et al. 1995). Trained pub­
lic health nurses carried out the standardized 
personal interviews based on a structured 
questionnaire between September 1988 
and December 1988. In August 2004, sub­
cohort participants were interviewed similarly 
through the same questionnaire again.
To determine the chronic As exposure 
indices of residents living in different locales 
with varying levels of iAs in well water, our 
questionnaire included residential history 
(e.g., villages of residence and duration) in 
addition to duration and source of water 
consumption. Arsenic levels in artesian well 
water were obtained from previous research 
of 155 well­water samples from 42 villages 
with endemic BFD (Kuo 1964). The cumu­
lative As exposure (CAE) index was used in 
our analysis to represent a cumulative dose of 
As in each study subject to reflect individual 
changes in residence, differing well­water As 
concentrations, and varying length of water 
consumption. The CAE was expressed in milli­
grams per liter­years (mg/L­year). It can then 
be calculated by the following formula: 
CAE = Σ (Ci × Di), 
where Ci is the median As concentration of 
well water (milligrams per liter) in the village 
where the subject lived, and Di is the dura­
tion in years of well­water consumption while 
residing in the village. The average As concen­
tration can then be calculated by the formula 
Σ (Ci × Di)/ ΣDi. 
The average arsenic As concentration and the 
CAE could not be calculated with precision 
for 54 study subjects (26.3%) who had 
returned or moved into the study villages after 
they lived in other areas for several years. CAE 
and the average As concentration for a given 
subject were considered to be unknown if the 
median As concentration of any village where 
the subject had resided during his or her life­
time was not available.
The cigarette smoking information was 
extracted from the questionnaires from both 
study periods. Residents were defined as non­
smokers if they denied ever smoking in their 
lives. Residents who smoked and never quit 
between the two study periods were defined 
as smokers. Those who quit cigarette smok­
ing before the 1989 interview or who had 
quit between the 1989 and 2004 interviews 
were defined as former smokers. Incident 
smokers are those who were originally classi­
fied as nonsmokers at the 1989 interview but 
had become smokers by the 2004 interview. 
Recurrent smokers were those who were for­
mer smokers at the 1989 interview but had 
become smokers again by the 2004 interview. 
A total of 5 participants were incident (1) or 
recurrent smokers (4) and were excluded from 
the analysis.
Determination of uAs species. A high­
performance liquid chromatography/hydride 
generator and an atomic absorption spectrom­
eter were used to measure urinary arsenite 
(AsIII), arsenate (AsV), MMAV, and DMAV. 
Analytical methods for uAs species determi­
nations are reported in our previous study 
(Hsueh et al. 1998). The quality assurance 
and control of the laboratory protocol in the 
Figure 1. Schematic overview of the recruitment of study subjects from three BFD-hyperendemic villages 
in southwestern Taiwan: 1989 (A) and 2004 (B).
2,258 residents (≥ 30 years of age) 
were registered with the household 
registration ofﬁce
1,571 (70%) were eligible and lived in
study villages ≥ 5 days a week
1,081 (69%) were interviewed from
September to December 1988
1,081 (100%) were invited to participate in health
examination during January and February 1989
305 (28%) died during 
February 1989–February 2004
529 (68%) did not participate
25 subjects with
incomplete
questionnaires
17 subjects who had
cancer in Tawain
cancer registry system
during 1989 to 2004
were excluded
247 (32%) participated in CCIS program
205 healthy subjects were included in the analysis
776 (72%) were invited to participate in Chayi
community-based integrated screening (CCIS)
program in August 2004
687 (30%) were not eligible
490 (31%) were not 
interviewed in 1988Huang et al.
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urine sample measurements were similar in 
1989 and 2004.
The As methylation indices are defined 
as the percentages of respective uAs species 
(AsIII, AsV, MMAV, and DMAV) present in 
urine samples, and U­Asmet is the sum of iAs 
and its metabolites (iAs + MMAV + DMAV). 
The primary methylation index (PMI) was 
defined as the ratio between MMAV and iAs 
levels, and the secondary methylation index 
(SMI) was defined as the ratio between 
DMAV and MMAV. To quantify the changes 
in uAs methylation profiles between 1989 
and 2004, the differences were calculated by 
subtracting the uAs methylation indices of 
1989 from those of 2004.
Statistical analyses. We used chi­square 
analysis to test for the association of categori­
cal variables and paired t­test to compare the 
uAs indices between 1989 and 2004. Analysis 
of variance (ANOVA) and Scheffe’s post hoc 
test were analyzed to compare uAs methyla­
tion indices among three or more groups. 
Multivariate regression analysis was carried 
out to study the relationship between differ­
ences in urinary methylation profiles with 
respect to age, sex, cigarette smoking status, 
and chronic As exposure indices.
Results
In Table 1, we show the distribution of demo­
graphic characteristics and lifestyles of the orig­
inal cohort in 1989 and the subcohort of 205 
cancer­free participants in the arseniasis area 
of southwestern Taiwan in 2004. The cancer­
free participants were generally younger and 
more educated than were the original cohort, 
and they had lower CAE and shorter dura­
tion of consuming high­As artesian well water. 
Because chronic arsenic exposure increases the 
risk of cancer (Chen et al. 1985, 1992; Wu 
et al. 1989), it is logical that the cancer­free 
participants had lower cumulative exposure to 
arsenic in the past.
Table 2 presents intraindividual differ­
ences in As methylation indices of residents 
in 1989 and 2004. Generally speaking, sam­
ples collected in 2004 had lower %iAs and 
%MMAV but higher %DMAV and SMI 
than did the urine samples collected in 1989. 
This finding suggests an overall increase in 
As metabolism efficiency during the 15­year 
period. We found no difference in the urinary 
PMI of samples collected in 1989 and 2004.
We also provide the correlation coefficients 
of uAs indices among healthy residents between 
1989 and 2004 (Table 3). The percentage of 
%iAs in 2004 was positively correlated with 
%MMAV in 1989 (r = 0.26, p < 0.001). The 
correlation coefficient of %iAs in 2004 was 
decreased with a %DMAV increment in 1989 
(r = –0.16, p < 0.05). We found a negative 
correlation between SMI in 1989 and %iAs in 
2004 (r = –0.17, p < 0.05). Conversely, SMI in 
1989 demonstrated a positive correlation with 
%DMAV in 2004 (r = 0.17, p < 0.05).
In Table 4, we demonstrate the inter­
individual difference of uAs species indices 
stratified by duration of high­As well­water 
consumption and age at baseline. The elderly 
(> 50 years) and those with a longer duration 
of high­As artesian well­water consumption 
(≥ 21 years) demonstrated significantly smaller 
changes in %MMAV from 1989 to 2004 than 
did the younger residents (< 50 years) and 
subjects who had consumed high­As well 
water for < 20 years.
Figure 2 depicts the interindividual differ­
ences in uAs methylation profiles between 1989 
and 2004 (calculated by subtracting methyla­
tion indices of 1989 from those of 2004). The 
differences in As methylation profiles were strat­
ified by age, sex, cigarette smoking status, CAE, 
and duration of high­As artesian well­water 
consumption. As shown in Figure 2A, U­Asmet 
levels dropped significantly more in males than 
in females (38.60 vs. 5.76 µg/L) and in former 
smokers than in smokers (62.4 vs. 12.69 µg/L). 
Table 1. Distribution of demographic and lifestyle characteristics of the cohort and subcohort partici-
pants in the arseniasis area of southwestern Taiwan.
Variable
1989 cohort 
(n = 1,081)
2004 followed healthy 
subcohort (n = 205)
Chi-square value 
(p-value)
Age at enrollment [years, n (%)]
30–39 265 (24.51) 67 (32.68) 18.37 (p < 0.01)
40–49 262 (24.24) 57 (27.80)
50–59 365 (33.77) 68 (33.17)
60–69 158 (14.62) 13 (6.34)
≥ 70 28 (2.59) 0 (0.00)
Data unavailable 3 (0.28) 0 (0.00)
Sex [n (%)]
Female 605 (55.97) 130 (63.41) 3.90 (p = 0.05)
Male 476 (44.03) 75 (36.59)
Education level [n (%)]
Elementary school or less 880 (81.41) 152 (74.15) 6.13 (p = 0.01)
Junior high school or higher 198 (18.32) 53 (25.85)
Data unavailable 3 (0.28) 0 (0.00)
Body mass index [kg/m2, n (%)]
< 24 434 (40.15) 91 (44.39) 0.54 (p = 0.76)
24–27 316 (29.23) 60 (29.27)
≥ 27 192 (17.76) 35 (17.07)
Data unavailable 139 (12.86) 19 (9.27)
Cigarette smoking status [n (%)]
Nonsmoker 831 (76.78) 167 (81.46) 1.90 (p = 0.17)
Smoker or former smoker 247 (22.85) 38 (18.54)
Data unavailable 3 (0.28) 0 (0.00)
Alcohol consumption [n (%)]
Never 938 (86.77) 182 (88.78) 0.49 (p = 0.49)
Current and former 140 (12.95) 23 (11.22)
Data unavailable 3 (0.28) 0 (0.00)
Chronic As exposure indices (mean ± SE)
Duration of high-As artesian well-water 
consumption (year)
21.45 ± 0.42 17.21 ± 0.84 p < 0.0001a
Average concentration of As in  
artesian well water consumed (mg/L)
 0.59 ± 0.01  0.55 ± 0.03 p = 0.16a
CAE (mg/L-year) 14.27 ± 0.38 10.73 ± 0.72 p < 0.0001a
Unavailable data were excluded in the statistical analyses.
ap-Value for Student t-test.
Table 2. Distribution of uAs species indices in 1989 and 2004.
Urinary samples
1989 2004 p-Value for 
paired t-test Species indices Mean SE Mean SE
uAs species level (µg/L)
iAs 4.85 0.30 1.42 0.11 < 0.0001
MMA 9.21 0.65 3.12 0.23 < 0.0001
DMA 60.80 3.61 52.55 2.81 0.06
U-Asmet 74.86 4.10 57.08 2.97 < 0.001
Percentage of uAs species 
%iAs 7.69 0.55 2.79 0.19 < 0.0001
%MMAV 12.56 0.56 5.76 0.36 < 0.0001
%DMAV 79.75 0.84 91.44 0.43 < 0.0001
PMI 2.74 0.23 4.56 1.40 0.24
SMI 9.86 0.66 49.99 16.22 0.02Changes in intraindividual arsenic methylation profile
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A multivariate regression model revealed 
significantly greater changes in U­Asmet in 
men than in women after adusting for age, 
cigarette smoking status, and any one of the As 
exposure indices (duration of high­As artesian 
well­water consumption, average concentra­
tion of As in artesian well water consumed, or 
CAE). Changes in %MMAV were influenced 
by age and the duration of high­As artesian 
well­ water consumption (Figure 2B). The 
older residents (≥ 50 years) showed a significant 
decrease in %MMAV compared with younger 
residents (< 50 years; 8.84% vs. 5.46%). The 
difference among %MMAV in residents who 
had consumed high­As artesian well water for 
≥ 21 years was significantly higher than among 
residents who had consumed high­As artesian 
well water for 1–20 years (8.77% vs. 5.95%). 
In addition, the %MMAV decreased further 
with increasing age after adjusting for sex, ciga­
rette smoking status, and any one of the As 
exposure indices.
Discussion
This is a unique study population with data 
on determinants of changes in uAs metabolite 
profiles after cessation of exposure to high­ 
level As water (700 µg/L) for 30–45 years. 
For the subjects in this study, the intrain­
dividual As methylation profiles appeared 
to have become more efficient during the 
15­year period. Other studies have demon­
strated that uAs methylation profiles remained 
fairly stable for 5 days among an Argentinean 
population exposed to As at 150–170 µg/L 
(Concha et al. 2002). Meanwhile, a study in 
Utah demonstrated that profiles were stable 
for 8–10 months after exposure to 20 µg/L As 
(Steinmaus et al. 2005).
Repeated oral exposure of AsV (0.5 mg 
As/kg) in mice had no effects on the uAs 
methylation profiles (Hughes et al. 2003). 
Therefore, in humans, other mechanisms may 
be responsible for changes in As methyla­
tion profiles after chronic exposure to As via 
daily drinking water. The saturation of the 
As methylation system may in part explain 
changes in the urinary profiles. In a study 
on four human volunteers, Buchet et al. 
(1981) extrapolated that the methylation may 
begin to become limiting at doses of about 
0.2–1 mg/day. Because only limited studies 
are available with very few subjects, data on 
the saturation of the methylation system in 
humans may not be well understood (ATSDR 
2000). Nevertheless, we suspect, based on this 
relatively small subset of previously published 
data, that the As methylation profiles may be 
stable if the As exposure is below a certain 
threshold. Further research is needed to deter­
mine the effects of As exposure on human tol­
erance and consequences of disease burden.
In the present study, we found the sub­
cohort of cancer­free residents to be more effi­
cient in methylating As (Table 2). One possible 
reason was demonstrated in an animal study by 
Kenyon et al. (2008), who found that mice 
preferentially accumulate MMA in the kid­
ney after subchronic exposure to AsV in drink­
ing water. Whether cancer­free subjects in this 
study also preferentially accumulate MMA in 
the kidney and its potential effect on cancer 
prevention remains to be seen. Another pos­
sible explanation may be related to renal func­
tion. Renal function is known to decline with 
age in humans (Mühlberg and Platt 1999). 
Renal function data were not available for this 
study; therefore, we were unable to determine 
its influence on the methylation profiles.
U­Asmet is a better index for estimating 
As toxicity (Calderon et al. 1999) than is the 
analysis of total As in urine because the lat­
ter would result in a higher As level (Le et al. 
1994) by including nonharmful As forms such 
as arsenobetaine, arsenocholine, and arseno­
sugars from seafood. U­Asmet was shown 
in other studies to be highly correlated with 
the total As concentration in drinking water 
(W­TotAs; r = 0.86) (Kurttio et al. 1998). As 
shown in Table 5, U­Asmet increased with 
W­TotAs in all studies (r = 0.56). The greater 
Table 3. Pearson correlation coefficients of uAs indices between 1989 and 2004 among healthy residents.
1989
2004 
%iAs %MMAV %DMAV PMI SMI U-Asmet
%iAs –0.02  –0.02 0.02  0.02 –0.09 0.00
%MMAV 0.26# 0.03 –0.14  –0.11 –0.04 –0.09
%DMAV –0.16**  –0.01 0.08  0.07 0.08 0.06
PMI 0.09  0.10 –0.13* –0.04 0.05 –0.05
SMI –0.17**  –0.11 0.17** 0.05 0.01 –0.02
U-Asmet 0.12*  0.03 –0.08  –0.06 –0.04 0.07
*0.05 < p < 0.1, **p < 0.05, #p < 0.01.
Table 4. Differences or changes in uAs species indices stratified by duration of high-As artesian well- 
water consumption [years (mean ± SE)] and baseline age.
 < 20 years ≥ 21 years
Arsenic species
Age < 50 years 
(n = 99)
Age ≥ 50 years 
(n = 17)
Age < 50 years 
(n = 25)
Age ≥ 50 years 
(n = 64)
%iAs –5.58 ± 1.04 –4.3 ± 1.6 –3.9 ± 1.37 –4.39 ± 0.67
%MMAV –4.90 ± 0.91* –7.53 ± 1.48 –7.69 ± 2.23 –9.19 ± 1.19*
%DMAV 10.48 ± 1.41 11.84 ± 2.31 11.59 ± 3.02 13.58 ± 1.39
PMI 4.05 ± 3.01 –1.75 ± 1.24 0.04 ± 1.59 –0.26 ± 0.47
SMI 54.53 ± 33.65 26.23 ± 8.27 25.23 ± 15.03 28.7 ± 7.46
U-Asmet –10.66 ± 5.52 –18.44 ± 9.16 –26.28 ± 25.66 –25.28 ± 8.31
*p < 0.05 by ANOVA and Scheffe’s test.
Figure 2. Changes in uAs species indices in 2004 versus 1989 (mean + SE). (A) U-Asmet level; (B) MMA percentage. 
*p < 0.05 by multiple regression model, adjusted for age, smoking status, and any one of the As exposure indices. **p < 0.01 by t-test. #p < 0.05 by ANOVA and Scheffe’s test. ##p < 0.05 by 
multiple regression model, adjusted for sex, smoking status, and any one of the arsenic exposure indices.
–100
–90
–80
–70
–60
–50
–40
–30
–20
–10
0
–16
–14
–12
–10
–8
–6
–4
–2
0
D
i
f
f
e
r
e
n
c
e
 
o
f
 
t
o
t
a
l
 
A
s
 
l
e
v
e
l
 
(
µ
g
/
L
)
D
i
f
f
e
r
e
n
c
e
 
o
f
 
M
M
A
 
p
e
r
c
e
n
t
a
g
e
F
e
m
a
l
e
A
g
e
 
(
<
 
5
0
 
y
e
a
r
s
)
A
g
e
 
(
≥
 
5
0
 
y
e
a
r
s
)
M
a
l
e
N
e
v
e
r
-
s
m
o
k
e
r
F
o
r
m
e
r
-
s
m
o
k
e
r
S
m
o
k
e
r
0
 
1
–
2
0
 
≥
 
2
1
 
≥
 
1
4
 
m
g
/
L
-
y
e
a
r
0
 
m
g
/
L
-
y
e
a
r
1
–
1
3
 
m
g
/
L
-
y
e
a
r
CAE
Duration of consuming 
high-As artesian well
water (years)
F
e
m
a
l
e
A
g
e
 
(
<
 
5
0
 
y
e
a
r
s
)
A
g
e
 
(
≥
 
5
0
 
y
e
a
r
s
)
M
a
l
e
N
e
v
e
r
-
s
m
o
k
e
r
F
o
r
m
e
r
-
s
m
o
k
e
r
S
m
o
k
e
r
0
 
1
–
2
0
 
≥
 
2
1
 
≥
 
1
4
 
m
g
/
L
-
y
e
a
r
0
 
m
g
/
L
-
y
e
a
r
1
–
1
3
 
m
g
/
L
-
y
e
a
r
CAE
Duration of consuming 
high-As artesian well
water (years)
** ## #
#
*Huang et al.
1864  v o l u m e  117 | n u m b e r 12 | December 2009  •  Environmental Health Perspectives
decrease of U­Asmet in the cancer­free group 
in this study could be due to the cessation of 
the exposure.
The U­Asmet:W­TotAs ratios can be 
used to represent the amount of As accumu­
lated in the body in relation to exposure to 
chronic and high levels of As from drink­
ing water. If the urinary excretion of As is 
100% attributable to the As intake, then the 
U­Asmet:W­TotAs ratio will trend toward 
1.0. The U­Asmet:W­TotAs ratio reported 
in one study in Inner Mongolia was differ­
ent from other reported studies, possibly 
because of differences in the handling of urine 
samples (samples from this previous study 
were exposed to 2 M sodium hydroxide and 
heated at 95°C for 3 hr before the determina­
tion of uAs species; Pi et al. 2002). With the 
exception of the Inner Mongolia study, the 
U­Asmet:W­TotAs ratios ranged from 0.65 to 
1.81 for populations exposed to As > 20 µg/L. 
The U­Asmet:W­TotAs ratio was < 1 in a 
Chilean population, which consumed water 
with As concentrations > 500 µg/L (Chung 
et al. 2002; Hopenhayn­Rich et al. 1996b). 
Hopenhayn­Rich et al. (1996a) found that the   
U­Asmet:W­TotAs ratio was 3.7 in Chile 
after changing As levels in the drinking water 
from 600 to 45 µg/L for 2 months. This find­
ing implied that As had accumulated in the 
Chilean subjects after chronic and heavy 
exposure to As through drinking water.
The As concentration allowance of public 
water supplies in Taiwan was changed from 
0 µg/L to a new standard of 10 µg/L in 2000. 
Thus, the U­Asmet:W­TotAs ratios increased 
from 1.50 (74.86/50) to 5.71 (57.08/10) dur­
ing the 15­year interval from 1989 to 2004. 
We cannot exclude the intake of seaweed 
that may have interfered with U­Asmet lev­
els. However, these residents had never left 
their townships, and it was reasonable to 
assume that they had not experienced any 
dramatic changes in their dietary habits over 
the course of this study. Our previous study 
also did not find an association between fre­
quencies of dietary intake of fish, shellfish, 
and seaweed and the levels of uAs species in 
subjects who drank tap water. In addition, 
As methylation patterns were similar before 
and after refraining from eating seafood for 
3 days (Hsueh et al. 2002). Therefore, the 
U­Asmet:W­TotAs ratio increased, support­
ing the hypothesis that As accumulates in the 
body of those individuals who had ever been 
exposed to chronic and high levels of As from 
drinking water.
Another interesting finding from the 
present study was the more pronounced 
decrease of %MMAV among members of the 
elderly cancer­free subcohort. The age of the 
cancer­free subcohort was highly correlated 
with the duration of artesian well­water con­
sumption (r = 0.62, p < 0.0001). Cellular As 
adaptation is a dynamic process that is medi­
ated by redox homeostasis and recycling of 
S­adenosylmethionine, as shown in a recently 
published in vitro study (Coppin et al. 2008). 
Urinary and skin %DMAV was increased in 
mice after repeated oral administration of AsV 
(Hughes et al. 2003; Kenyon et al. 2008). 
We suspect that the As adaptation among the 
elderly cancer­free subcohort in the present 
study may play a role in the significant drop in 
%MMAV and requires further investigation.
The possibility of genetic contribution 
to As methylation efficiency was also sug­
gested by studies of native women of the 
Andes excreting low urinary levels of MMA 
(2.3–3.5%) regardless of drinking water 
As levels (Concha et al. 1998; Vahter et al. 
1995). Polymorphisms of genes related to As 
methylation may also contribute to the dif­
ferences in As methylation profiles. Studies 
have shown that polymorphisms of MMA 
reductase or As methyltransferase are related 
to uAs methylation profiles (Marnell et al. 
2003; Schmuck et al. 2005; Wood et al. 
2006). Recently, polymorphisms of As meth­
yltransferase also have been shown to affect 
the ratio of MMA to DMA in urine (Fujihara 
et al. 2008; 2009; Hernandez et al. 2008). 
Therefore, genetic controls over the regulatory 
enzymes of As metabolism may partly explain 
the substantial variations in As methylation 
efficiency among different ethnicities.
Two novel As species, monomethyl­
arsonous acid (MMAIII) and dimethylarsin­
ous acid (DMAIII), were recently identified 
in urine (Mandal et al. 2001; Valenzuela 
et al. 2005). These two novel species were 
thought to be the more toxic intermediates in 
the biotransformation of ingested iAs (Styblo 
et al. 2000; Thomas et al. 2001; Vega et al. 
2001). The detection of the transient metabo­
lites of MMAIII and DMAIII depends on the 
conditions of sample storage and their con­
centration in the urine, which was beyond 
the analytical detection at the time of this 
study in 1989. Thus, it is difficult to use these 
tri  valent As metabolites as a marker for this 
study. Further investigations focusing on the 
association between these highly toxic species 
of As metabolic intermediates and clinical dis­
eases could be potentially meaningful.
Certain limitations of this study should 
be noted. First, we had a low response rate 
Table 5. Urinary arsenic methylation profiles in adult populations who were exposed to As through drinking water.
As concentration (µm/L)
Metabolite distribution (%) W-TotAs U-Asmet U-Asmet:
Country No.  (mean) (mean) W-TotAs ratio iAs MMA DMA Reference
Argentina 11 200 261.0 1.31 26.0 2.3 72.0 Vahter et al. 1995
14 23 27.0 1.17 42.0 3.5 54.0 Vahter et al. 1995
37 210 233.0a 1.11 14.0a 3.1a 83.0a Concha et al. 1998
110 210 272.0a 1.30 12.0a 7.4a 80.0a Schläwicke Engström et al. 2007
Chile 122 600 583.0 0.97 18.4 15.0 66.6 Hopenhayn-Rich et al. 1996b
98 15 61.0 4.07 14.9 10.6 74.5 Hopenhayn-Rich et al. 1996b
44 750 490.2 0.65 16.8 13.9 69.3 Chung et al. 2002
Mexico 35 408 739.8 1.81 31.8 13.7 54.5 Gonsebatt et al. 1997
34 30 34.0 1.13 7.7 5.2 87.1 Gonsebatt et al. 1997
10 17 28.0 1.65 16.4 15.0 67.1 Meza et al. 2004
9 8 31.1 3.89 25.4 9.3 55.6 Meza et al. 2004
10 5 30.8 6.16 22.9 7.5 47.7 Meza et al. 2004
Finland 35 170 58.0b 19.0b 9.0b 67.0b Kurttio et al. 1998
9 < 1 5b 22.0b 9.0b 59.0b Kurttio et al. 1998
Northeastern Taiwan 242 93 96.9 1.04 11.9 14.2 74.2 Hsueh et al. 2003
Taipei, Taiwan 313 10 25.5 2.55 5.5 7.9 86.6 Pu et al. 2007
Inner Mongolia, China 43 410 2,387.0 5.82 15.1 19.6 65.3 Pi et al. 2002
10 20 263.0 13.15 27.0 15.2 57.8 Pi et al. 2002
Bangladesh 1,041 96 133.0b 1.39 15.8 12.6 70.7 Ahsan et al. 2007
24 373 484.0 1.30 18.5 17.7 64.3 Chowdhury et al. 2003
24 3 21.0 7.01 21.1 15.4 63.5 Chowdhury et al. 2003
aMedian. bGeometric mean.Changes in intraindividual arsenic methylation profile
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and limited sample sizes, a high proportion of 
women, and the past As exposure among the 
subcohort of 205 cancer­free participants was 
low. Thus, it may not be possible to general­
ize or extrapolate the results of this study to 
other populations. Second, the 15­year inter­
val is too long to exclude other factors that 
might have influenced the As methylation 
profiles, including As levels in drinking water 
and other environmental sources such as sea­
weed, occupational exposure, and air contam­
ination. Nutritional status and dietary intake 
may also be uncontrollable factors during 
the long study interval. Arsenic methylation 
involves the addition of a methyl group to iAs 
or MMA. This one­carbon metabolism can 
be influenced by dietary substances such as 
cysteine, methionine, folic acid, vitamin B12, 
and choline in food (Ahsan et al. 2007; Chen 
et al. 2007; Gamble et al. 2005; Schläwicke 
Engström et al. 2009; Vahter 2007). Other 
studies have indicated that, under normal 
conditions, As methylation is not enhanced 
by supplementation with methyl donors in 
humans (Buchet et al. 1982) or in animals 
(Buchet and Lauwerys 1987). Although no 
data were available on the change in nutrition 
status, we found that baseline body mass index 
was not associated with changes in urinary As 
methylation profiles (data not shown).
In conclusion, the As methylation pro­
files appeared to become more efficient among 
subjects after cessation of long­term exposure 
to high levels of As. Moreover, the decrease 
of %MMAV was more pronounced among 
elderly cancer­free subcohort subjects. These 
results may have implications for As mediation 
strategies in areas currently exposed to poten­
tially harmful levels of As in drinking water.
RefeRences
Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, 
et al. 2007. Arsenic metabolism, genetic susceptibility, and 
risk of premalignant skin lesions in Bangladesh. Cancer 
Epidemiol Biomarkers Prev 16:1270–1278.
ATSDR. 2000. Toxicological Profile for Arsenic. Atlanta, 
GA:Agency for Toxic Substances and Disease Registry. 
Available: http://www.atsdr.cdc.gov/toxprofiles/tp2.
html#bookmark06 [accessed 7 October 2009].
Buchet JP, Lauwerys R. 1987. Study of factors influencing the 
in vivo methylation of inorganic arsenic in rats. Toxicol 
Appl Pharmacol 91:65–74.
Buchet JP, Lauwerys R, Mahieu P, Geubel A. 1982. Inorganic 
arsenic metabolism in man. Arch Toxicol Suppl 5:326–327.
Buchet JP, Lauwerys R, Roels H. 1981. Urinary excretion of 
inorganic arsenic and its metabolites after repeated inges-
tion of sodium metaarsenite by volunteers. Int Arch Occup 
Environ Health 48:111–118.
Calderon  RL,  Hudgens  E,  Le  XC,  Schreinemachers  D, 
Thomas DJ. 1999. Excretion of arsenic in urine as a func-
tion of exposure to arsenic in drinking water. Environ 
Health Perspect 107:663–667.
Chen CJ, Chen CW, Wu MM, Kuo TL. 1992. Cancer potential in 
liver, lung, bladder and kidney due to ingested inorganic 
arsenic in drinking water. Br J Cancer 66:888–892.
Chen CJ, Chuang YC, Lin TM, Wu HY. 1985. Malignant neo-
plasms among residents of a blackfoot disease-endemic 
area in Taiwan: high-arsenic artesian well water and 
cancers. Cancer Res 45:5895–5899.
Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, et al. 
1995. Increased prevalence of hypertension and long-term 
arsenic exposure. Hypertension 25:53–60.
Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, 
Parvez F, et al. 2007. Arsenic exposure from drinking water, 
dietary intakes of B vitamins and folate, and risk of high 
blood pressure in Bangladesh: a population-based, cross-
sectional study. Am J Epidemiol 165:541–552.
Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 
2003a. Arsenic methylation and skin cancer risk in south-
western Taiwan. J Occup Environ Med 45:241–248.
Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 
2003b. Arsenic methylation and bladder cancer risk in 
Taiwan. Cancer Causes Control 14:303–310.
Chowdhury UK, Rahman MM, Sengupta MK, Lodh D, Chanda CR, 
Roy S, et al. 2003. Pattern of excretion of arsenic com-
pounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of 
children compared to adults from an arsenic exposed area 
in Bangladesh. J Environ Sci Health Part A Toxic/Hazard 
Subst Environ Eng 38:87–113.
Chung JS, Kalman DA, Moore LE, Kosnett MJ, Arroyo AP, 
Beeris M, et al. 2002. Family correlations of arsenic 
methyla  tion patterns in children and parents exposed to 
high concentrations of arsenic in drinking water. Environ 
Health Perspect 110:729–733.
Concha G, Nermell B, Vahter MV. 1998. Metabolism of inor-
ganic arsenic in children with chronic high arsenic 
exposure in northern Argentina. Environ Health Perspect 
106:355–359.
Concha G, Vogler G, Nermell B, Vahter M. 2002. Intra-individual 
variation in the metabolism of inorganic arsenic. Int Arch 
Occup Environ Health 75:576–580.
Coppin JF, Qu W, Waalkes MP. 2008. Interplay between cellular 
methyl metabolism and adaptive efflux during oncogenic 
transformation from chronic arsenic exposure in human 
cells. J Biol Chem 283:19342–19350.
Dewar WA, Lenihan JM. 1956. A case of chronic arsenical 
poisoning; examination of tissue samples by activation 
analysis. Scott Med J 1:236–238.
Fujihara J, Fujii Y, Agusa T, Kunito T, Yasuda T, Moritani T, et al. 
2009. Ethnic differences in five intronic polymorphisms 
associated with arsenic metabolism within human arsenic 
(+3 oxidation state) methyltransferase (AS3MT) gene. 
Toxicol Appl Pharmacol 234:41–46.
Fujihara J, Soejima M, Koda Y, Kunito T, Takeshita H. 2008. 
Asian specific low mutation frequencies of the M287T 
polymorphism in the human arsenic (+3 oxidation state) 
methyltransferase (AS3MT) gene. Mutat Res 654:158–161.
Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, 
et al. 2005. Folate, homocysteine, and arsenic metabolism 
in arsenic-exposed individuals in Bangladesh. Environ 
Health Perspect 113:1683–1688.
Gonsebatt ME, Vega L, Salazar AM, Montero R, Guzman P, 
Blas J, et al. 1997. Cytogenetic effects in human exposure 
to arsenic. Mutat Res 386:219–228.
Hernández A, Xamena N, Sekaran C, Tokunaga H, Sampayo-
Reyes A, Quinteros D, et al. 2008. High arsenic metabolic 
efficiency in AS3MT287Thr allele carriers. Pharmacogenet 
Genomics 18:349–355.
Hindmarsh JT. 2002. Caveats in hair analysis in chronic arsenic 
poisoning. Clin Biochem 35:1–11.
Hopenhayn-Rich  C,  Biggs  ML,  Kalman  DA,  Moore  LE, 
Smith AH. 1996a. Arsenic methylation patterns before 
and after changing from high to lower concentrations 
of arsenic in drinking water. Environ Health Perspect 
104:1200–1207.
Hopenhayn-Rich  C,  Biggs  ML,  Smith  AH,  Kalman  DA, 
Moore LE. 1996b. Methylation study of a population envi-
ronmentally exposed to arsenic in drinking water. Environ 
Health Perspect 104:620–628.
Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, 
et al. 1997. Serum beta-carotene level, arsenic methylation 
capability, and incidence of skin cancer. Cancer Epidemiol 
Biomarkers Prev 6:589–596.
Hsueh YM, Hsu MK, Chiou HY, Yang MH, Huang CC, Chen 
CJ. 2002. Urinary arsenic speciation in subjects with or 
without restriction from seafood dietary intake. Toxicol 
Lett 133:83–91.
Hsueh YM, Huang YL, Huang CC, Wu WL, Chen HM, Yang MH, 
et al. 1998. Urinary levels of inorganic and organic arse-
nic metabolites among residents in an arseniasis- 
hyperendemic area in Taiwan. J Toxicol Environ Health A 
54:431–444.
Hsueh YM, Ko YF, Huang YK, Chen HW, Chiou HY, Huang YL, 
et al. 2003. Determinants of inorganic arsenic methylation 
capability among residents of the Lanyang Basin, Taiwan: 
arsenic and selenium exposure and alcohol consumption. 
Toxicol Lett 137:49–63.
Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, 
et al. 2008. Arsenic exposure, urinary arsenic speciation, 
and the incidence of urothelial carcinoma: a twelve-year 
follow-up study. Cancer Causes Control 19(8):829–839.
Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM. 
2007. Arsenic methylation capability and hypertension risk in 
subjects living in arseniasis-hyperendemic areas in south-
western Taiwan. Toxicol Appl Pharmacol 218:135–142.
Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Razo LM, 
Thomas DJ. 2003. Accumulation and metabolism of arse-
nic in mice after repeated oral administration of arsenate. 
Toxicol Appl Pharmacol 191:202–210.
IARC (International Agency for Research on Cancer). 1980. 
Some Metals and Metallic Compounds. IARC Monogr Eval 
Carcinog Risk Hum 23:1–438.
Kenyon EM, Hughes MF, Adair BM, Highfill JH, Crecelius EA, 
Clewell HJ, et al. 2008. Tissue distribution and urinary 
excretion of inorganic arsenic and its methylated metab-
olites in C57BL6 mice following subchronic exposure 
to arsenate in drinking water. Toxicol Appl Pharmacol 
232:448–455; doi:10.1016/j.taap.2008.07.018 [Online 28 July 
2008].
Kuo TL. 1964. Arsenic content of artesian well water in endemic 
area of chronic arsenic poisoning. Rep Inst Pathol Natl 
Taiwan Univ 20:7–13.
Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J. 1998. 
Urinary excretion of arsenic species after exposure to 
arsenic present in drinking water. Arch Environ Contam 
Toxicol 34:297–305.
Le XC, Cullen WR, Reimer KJ. 1994. Human urinary arsenic 
excretion after one-time ingestion of seaweed, crab, and 
shrimp. Clin Chem 40:617–624.
Mandal BK, Ogra Y, Suzuki KT. 2001. Identification of dimethyl-
arsinous and monomethylarsonous acids in human urine 
of the arsenic-affected areas in West Bengal, India. Chem 
Res Toxicol 14:371–378.
Marafante E, Bertolero F, Edel J, Pietra R, Sabbioni E. 1982. 
Intracellular interaction and biotransformation of arsenite 
in rats and rabbits. Sci Total Environ 24:27–39.
Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, 
Walsh B, Avram MD, et al. 2003. Polymorphisms in the 
human monomethylarsonic acid (MMA V) reductase/
hGSTO1 gene and changes in urinary arsenic profiles. 
Chem Res Toxicol 16:1507–1513.
Meza MM, Kopplin MJ, Burgess JL, Gandolfi AJ. 2004. Arsenic 
drinking water exposure and urinary excretion among 
adults in the Yaqui Valley, Sonora, Mexico. Environ Res 
96:119–126.
Mühlberg W, Platt D. 1999. Age-dependent changes of the 
kidneys: pharmacological implications. Gerontology 
45:243–253.
Pi J, Yamauchi H, Kumagai Y, Sun G, Yoshida T, Aikawa H, 
et al. 2002. Evidence for induction of oxidative stress 
caused by chronic exposure of Chinese residents to arse-
nic contained in drinking water. Environ Health Perspect 
110:331–336.
Pu YS, Yang SM, Huang YK, Chung CJ, Huang SK, Chiu 
AW-H, et al. 2007. Urinary arsenic profile affects the risk 
of urothelial carcinoma even at low arsenic exposure. 
Toxicol Appl Pharmacol 218:99–106.
Schläwicke Engström K, Broberg K, Concha G, Nermell B, 
Warholm M, Vahter M. 2007. Genetic polymorphisms influ-
encing arsenic metabolism: evidence from Argentina. 
Environ Health Perspect 115:599–605.
Schläwicke Engström K, Nermell B, Concha G, Stromberg U, 
Vahter M, Broberg K. 2009. Arsenic metabolism is 
influenced by polymorphisms in genes involved in 
one-carbon metabolism and reduction reactions. Mutat 
Res 667(1–2):4–14.doi:10.1016/j.mrfmmm.2008.07.003 
[Online 10 July 2009].
Schmuck  EM,  Board  PG,  Whitbread  AK,  Tetlow  N, 
Cavanaugh JA, Blackburn AC, et al. 2005. Characterization 
of the monomethylarsonate reductase and dehydro-
ascorbate reductase activities of omega class glutathione 
transferase variants: implications for arsenic metabo-
lism and the age-at-onset of Alzheimer’s and Parkinson’s 
  diseases. Pharmacogenet Genomics 15:493–501.
Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, 
et al. 2006. Arsenic methylation and bladder cancer risk in 
case-control studies in Argentina and the United States. 
J Occup Environ Med 48:478–488.Huang et al.
1866  v o l u m e  117 | n u m b e r 12 | December 2009  •  Environmental Health Perspectives
Steinmaus C, Yuan Y, Kalman D, Atallah R, Smith AH. 2005. 
Intraindividual variability in arsenic methylation in a U.S. 
population. Cancer Epidemiol Biomarkers Prev 14:919–924.
Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, 
Hamilton GA, et al. 2000. Comparative toxicity of trivalent 
and pentavalent inorganic and methylated arsenicals in 
rat and human cells. Arch Toxicol 74:289–299.
Thomas DJ, Styblo M, Lin S. 2001. The cellular metabolism 
and systemic toxicity of arsenic. Toxicol Appl Pharmacol 
176:127–144.
Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, 
et al. 2005. Arsenic exposure, urinary arsenic speciation, 
and peripheral vascular disease in blackfoot disease-
hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 
206:299–308.
Vahter M. 1999. Methylation of inorganic arsenic in differ-
ent mammalian species and population groups. Sci Prog 
82:69–88.
Vahter M. 2000. Genetic polymorphism in the biotransformation 
of inorganic arsenic and its role in toxicity. Toxicol Lett 
112–113:209–217.
Vahter ME. 2007. Interactions between arsenic-induced toxic-
ity and nutrition in early life. J Nutr 137:2798–2804.
Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan AT. 
1995. A unique metabolism of inorganic arsenic in native 
Andean women. Eur J Pharmacol 293:455–462.
Vahter M, Norin H. 1980. Metabolism of 74As-labeled trivalent and 
pentavalent inorganic arsenic in mice. Environ Res 21:446–457.
Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-
Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, 
et al. 2005. Urinary trivalent methylated arsenic species 
in a population chronically exposed to inorganic arsenic. 
Environ Health Perspect 113:250–254.
Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D. 
2001. Differential effects of trivalent and pentavalent 
arsenicals on cell proliferation and cytokine secretion 
in normal human epidermal keratinocytes. Toxicol Appl 
Pharmacol 172:225–232.
Wood TC, Salavaggione OE, Mukherjee B, Wang L, Klumpp AF, 
Thomae BA, et al. 2006. Human arsenic methyltransferase 
(AS3MT) pharmacogenetics: gene resequencing and func-
tional genomics studies. J Biol Chem 281:7364–7373.
Wu HY, Chen KP, Tseng WP, Hsu CL. 1961. Epidemiologic stud-
ies on blackfoot disease: I. Prevalence and incidence of 
the disease by age, sex, occupation and geographical 
distribution. Mem College Med Natl Taiwan Univ 7:33–50.
Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989. Dose-response 
relation between arsenic concentration in well water 
and mortality from cancers and vascular diseases. Am J 
Epidemiol 130:1123–1132.
Yamauchi H, Yamamura Y. 1985. Metabolism and excretion 
of orally administrated arsenic trioxide in the hamster. 
Toxicology 34:113–121.
Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation 
capacity and skin cancer. Cancer Epidemiol Biomarkers 
Prev 9:1259–1262.